Perrigo Misses Expectations and Cuts Guidance

Drugmaker Perrigo missed earnings expectations for the latest quarter and cut its full-year guidance as it continues to battle pricing pressure and competition.

from WSJ.com: US Business http://ift.tt/2aBk0ah
via IFTTT